Brief: Neurosense To Present At The Als And Alzheimer's Disease At Ad/Pd™ 2023 Advances In Science & Therapy Conference
23/03/2023 13:07
March 23 (Reuters) - Neurosense Therapeutics Ltd
NRSN.O :
* NEUROSENSE TO PRESENT AT THE ALS AND ALZHEIMER'S DISEASE
AT
AD/PD™ 2023 ADVANCES IN SCIENCE & THERAPY CONFERENCE
* NEUROSENSE THERAPEUTICS LTD - PRIMEC IS CURRENTLY BEING
EVALUATED FOR TREATMENT OF ALS IN A PHASE 2B STUDY WITH TOPLINE
RESULTS EXPECTED IN H2 2023
* NEUROSENSE THERAPEUTICS LTD - PHASE 2 DOUBLE-BLIND
PROOF-OF-CONCEPT AD STUDY IS EXPECTED TO COMMENCE IN H1 2023
Source text for Eikon: ID:nPncfNwBwa
Further company coverage: NRSN.O
((Reuters.Briefs@thomsonreuters.com;;))